Hyloris Bolsters Management Team Following Approvals
Appoints COO Following Maxigesic IV Nods In Eight European Countries
Belgian value-added medicines specialist Hyloris Pharmaceuticals has bolstered its management team with the appointment of a chief operating officer, shortly after receiving eight European approvals for its Maxigesic IV pain treatment.
